Federated Hermes, Inc. 13D and 13G filings for Orchard Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-10 11:39 am Purchase | 2023-03-31 | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 840,169 4.570% | 0 (+0.00%) | Filing |
| 2023-02-01 11:25 am Purchase | 2022-12-31 | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 840,169 6.630% | 9,183 (+1.11%) | Filing |
| 2022-02-14 1:26 pm Purchase | 2021-12-31 | 13G | Orchard Therapeutics plc ORTX | FEDERATED HERMES INC. FHI | 830,986 6.620% | 830,986 (New Position) | Filing |